Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang în acțiuni #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Preț acțiune
$0.78611575
Capitalizare de piață
$60.45M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-12.06%
Țară
NO
Tranzacționează Lytix Biopharma AS (LYTIX)

Categorie

Istoricul randamentului dividendelor pentru Lytix Biopharma AS (LYTIX)
Randamentul dividendelor (TTM) pentru Lytix Biopharma AS (simbol acțiune: LYTIX) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Lytix Biopharma AS (LYTIX) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH